Rationale and design of the ETN-STEP (Early administration of Tirofiban in mid to high risk patients with non-ST elevation acute coronary syndrome referred for percutaneous coronary intervention) project: A multi-center, randomized, controlled clinic tria

Jian-Ping Li; Qun Liu; Yong Huo

doi:10.3724/SP.J.1263.2012.02272

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Rationale and design of the ETN-STEP (Early administration of Tirofiban in mid to high risk patients with non-ST elevation acute coronary syndrome referred for percutaneous coronary intervention) project: A multi-center, randomized, controlled clinic tria

DOI: 10.3724/SP.J.1263.2012.02272

Rationale and design of the ETN-STEP (Early administration of Tirofiban in mid to high risk patients with non-ST elevation acute coronary syndrome referred for percutaneous coronary intervention) project: A multi-center, randomized, controlled clinic tria

Jian-Ping Li

Qun Liu

Yong Huo

Keywords：Acute coronary syndromePercutaneous coronary interventionGlycoprotein IIb/IIIa receptorTirofibanThrombolysis in myocardial infarction

Publication Date：2012-09-30

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 375-378 )

JOURNAL OF GERIATRIC CARDIOLOGY

CSCD

ISSN：1671-5411

Year, Vol.(Issue)：2012,9(4)